- Home Page
- For Health Professionals
- Healthy Vaginal Flora
- Efficacy and Dosing:
- Dual Therapy
- Tolerability
- Tindamax® (tinidazole) Drug Facts:
- Order Tindamax® Samples and Literature
- Wholesaler Order Entry Numbers
- CDC STD Treatment Guidelines
- Patient Counseling Information
- Website References
- Prescribing Information
- For Patients
- About Tindamax® (tinidazole)
- Press/Media:
- Press Releases
- 7/31/2007 – New Study Finds Tindamax® To Be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
- 5/24/2007 – FDA Approves Tindamax® for Bacterial Vaginosis
- 11/13/2006 – CDC Recommends Tindamax® for the Treatment of Trichomoniasis
- 8/17/2007 – Mission Pharmacal Submits Supplemental New Drug Application for Tindamax® (Tinidazole) as Treatment of Bacterial Vaginosis
- 5/9/2006 – Most Common Curable STD a Significant Public Health Concern When Untreated, May Contribute to Spread of HIV
- 5/8/2006 – Mission Pharmacal Completes Phase III Study of Tindamax® for the Treatment of Bacterial Vaginosis
- 4/20/2006 – Mission Pharmacal Acquires Tindamax®: Treatment for Trichomoniasis, Most Common Non-Viral Sexually Transmitted Disease
- News
- Fact Sheets
- Press Releases
- Legal/Privacy
- Report an Adverse Event
- Contact
- Tindamax.com Site Map
Only Tindamax® is approved to treat both bacterial vaginosis and trichomoniasis (TV).
Clinical Insight
Oral vs vaginal cream therapy: Patient preference for oral dosing is demonstrated to be 84%. More»
Beyond BV
Tindamax® may be prescribed for other infections including:
The Mission Pharmacal family of products
Learn more about innovative therapies including...
CitraNatal®Calcium citrate with vital nutrients for mother and baby » Ferralet® 90The iron therapy with biocomplementary absorption » Urocit®-KKidney stone therapy with wax-matrix delivery for slow, sustained release »
